TNXP OpportunityTNXP has settled on it's 1.618 fib retracement and has found solid support at this price. I am long TNXP as I believe it will jump back up to it's first resistance at 0.81 in the coming months.
Not financial advice
TNXP trade ideas
TNXP - I Wouldn't Buy This With Your MoneyJust a quickie.
Don't let me wriggle you out of the jackpot of a lifetime these are just my thoughts.
Same goes for any chart that only goes down, until it goes up.
Not advice.
TNXPTonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) This penny stock deserves your attention going forward. The stock is forming an inverted head and shoulders pattern. If the stock can break Friday’s high of 44c, we should see a strong follow through move. TNXP will move very quickly, so keep a very close eye on the stock.
Reached the all time low. Hi everyone, Yurii Domaranskyi here. Let's take a look at the chart:
1. Price levels are working well.
2. Globally range, locally downtrend
3. there was no confirmation of the level before 2 days ago, you can see nicely on the m5 chart the players see the price level.
4. Distant test of the level
5. approached with bars a little bigger than usual, but no paranormal
6. approached slowly
7. there was accumulation before the level
8. there was a rollback
9. the instrument closed above the level
10. all-time low low level, from there, was made a huge move up
11. there is enough room for a move 1 to 5.1 r/r
12. no model descending lows, we can see the engulfing bar on daily
13. no news for the last 10 days
14. the price came from the above
15. the price has a big potential for reversal
16. no planned report in the next 2 weeks
Potential risk/reward ratio = 1 to 5.1 meaning that potential risk 100$ with the possibility to make 510$
If you find the work valuable, please, press a thumb up! 👍
TNXP - Could See $0.029!?TNXP breaking down from what appears to be a bear flag.
It tested but failed to find any support above the 20Mma.
Playing out as I said it would in my previous thread.
Next fibonacci step down is the 0.618 at $0.029.
Seems quite extreme but I just do the weather and thats the forecast.
Not advice.
TNXP Winter RallyZero Debt
Positive Earnings Report
5 pieces of POSITIVE news within the last month (including a COVID drug prospect)
I've got some serious FOMO with this one.
TNXP - Possible TradeHello There,
TNXP in a very strong support area , also they announced a positive earnings after a bad 3Q.
I expect this to start pushing the price toward the 0.5 Fib area (0.98$).
SL will be the yellow line, and targets are the fib levels.
Cheers.
TNXP Trend ReversalAfter months of nothing but sadness...TNXP showed up with some hope.
Positive Phase 1 Trial for their Depression Drug
The best Earnings Surprise (30%) that they have had to date. How did they pull that off?
There is something positive that generated that unaccounted for % increase...THAT WE DO NOT KNOW ABOUT YET!
The estimates on this stock were getting narrower and narrower. WS seemed to have a pretty good handle on what they would be bringing in.
But there is an UNACCOUNTED FOR ....20%
This stock is also one of those Russell-Runners...it will be hot till Mid-Feb. Last year it went up to 2.12 from about the same place we are now.
Do you know what date that increase started? Nov 9...the day they released their first positive earnings report in 4 months (sound familiar?)
Set you a stop-loss @ .55 and run with me!
TNXPTonix Pharmaceuticals
• Falling Wedge
• Bullish Deep Crab Harmonic Pattern
• Price Hit The Demand Zone
• 1st Higher Low
• Possible Trend Reversal From A Long
Downtrend
• Long-term HODL
• Earnings Report 5th November
• New Lab Acquired Recently
Possible of a big move up for TNXPBeen DCAing into this for a bit now. Looks good for a POSSIBLE big move to the upside tomorrow.
Key levels for TNXPWish you all the best, these are the key levels i identified for the future of TNXP
I love this chartcrab harmonic pattern:
X=$31
AB=0.38 XA
BC=0.88 AB
tp1=1.6 BC=$4.8
tp2=2.6 BC=$19
tp3=3.6 BC=$78
tp4=1.6 XA=$410
TNXPShares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are starting to heat up again and are worth watching in the coming future. Phase 3 results of Tonmya (TNX-102 SL) to be presented at ACR November 6, 2021 If volume can pick up, I think this stock can break through resistance at 60c and re-test its recent highs around 80c (gap zone).
TNXP 1-Month AnalysisThis is a NEWS stock. It lives and dies off of NEWS. Technical analysis ONLY will yield frustration. This stock must be invested in based on more than chart analysis. My personal reason for backing this one is two-fold. 1) They have NO debt. 2) They have a diverse PIPELINE that includes a COVID vaccine (1 and done...no every 4-month headache, no boosters...can you imagine?)
* - Initial drop due to negative (yet very subjective) early clinical trial results. Conducted simple clinical trial with placebo vs TNX-102 and based findings off of patients' self-evaluation of pain. Relying on the patients' pain scale is highly subjective. On top of that, they elected to see results too quick. Both of those factors combined can easily make for inaccuracies. This was not a strong enough news break to merit the kind of sell-off that took place. Previous clinical results were far more substantive and thorough. How quickly we forget.
** - Notice the change in volume since the drop. Yes, more shares are changing places because the price is lower and buying on the dip is popular, but this kind of sustainable increase in volume suggests institutional involvement. While the price is sitting down here (where it shouldn't be), Wall Street is loading up.
*** - The lowest TNXP went this year is .50. If this threshold breaks down, it will probably take a lot longer to get back to where it was.
**** - The highest TNXP reached this year was 2.11. From the bottom to the top is about a 300% difference. Analyst average PT is set at $3.25. From where we are now, that's a 500% increase. It is also a popular ROBINHOOD stock which means it has a backdoor possibility at a MOONSHOT. This clinical trial isn't over, they are not packing up and starting over.
Not a financial advisor The reason I am long on TNXP. On the day chart its clearly had its time in the gutter long enough to know how to climb out of it. With everything TNXP has going on and the support of the US government I believe TNXP time has come. I predict up at least to $3 by EOY. I've been buying as much as I can while under $1. Have a nice day!
“Our clinical, manufacturing, and regulatory teams are advancing four programs into clinical trials by the end of 2021,” said Seth Lederman, M.D., President and Chief Executive Officer. “We look forward to initiating Phase 2 studies of TNX-1300 for cocaine intoxication and TNX-1900 for chronic migraine in the third and fourth quarters of 2021, respectively. We also expect to initiate a Phase 3 study of TNX-102 SL for PTSD outside of the U.S. and a first-in-human study of TNX-2100, a skin test diagnostic for COVID-19 T cell immunity, in the fourth quarter of 2021.”
Dr. Lederman continued, “We are expanding our R&D and manufacturing facilities. In July we announced an agreement to acquire an infectious disease research facility in Frederick, MD, and earlier this month we began construction on our Advanced Development Center (ADC) in New Bedford MA. We expect these facilities, coupled with our planned commercial scale manufacturing facility for vaccines in Hamilton, MT, will enable us to avoid future outsourcing bottlenecks and to work with greater efficiency in developing our programs for COVID-19, its variants, and other infectious diseases.”
Dr. Lederman added, “Recent reports of COVID-19 outbreaks in the U.S. and elsewhere, due primarily to the Delta variant, point to the urgent needs for more robust vaccines and more potent antiviral therapeutics. We believe the recent steps we have taken to strengthen our internal capabilities with company-controlled R&D and manufacturing facilities will accelerate our full pipeline of COVID-19 product candidates, which currently includes the TNX-1800 vaccine, TNX-3500 antiviral, TNX-2100 diagnostic, and TNX-102 SL for treating Long COVID.”
ir.tonixpharma.com
TNXP..................any price target? tnxIt looks like accumulation has took place ....but in this case possibility of rs is always under the corner.
TNXP: Breakout Confirmed, 44.04% Potential Profit!Description: TNXP is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position.
Stats:
1. Ideal buy range: $1.1 - $1.2
2. Take profit: $1.57
3. Stop Loss: $1
4. Risk To Reward: 1 / 6
5. Accuracy Rating: 90%
TNXP high potential and hopes. With TNXP developing a new covid vaccine named TNX-1800, I think it looks bullish af. They are now in between phase 1 and 2 with the vaccine and it is expected that they will announce the results in July. With janssen&janssen or astrazeneca vaccines doing bad I think TXNP has a lot of potential. We know what happend to OCGN when they announced their vaccine, so Im hoping to see the same here with TNXP.
Chart also looks good and if everything goes well my TP1 is 2 dollars and if we break that 4 and 6 dollars will follow.
Cheers!
calculation of targets of the unpredictable stock!crab harmonic targets:
AB=0.38 XA
BC=0.88 AB
tp1=2.6 BC=$32
tp2=3.6 BC=$160
tp3=1.6 XA=$750
other possible targets:
tp4=0.88 AB=$2 *reached*
tp5=1.6 BC=$6.7
tp6=0.88 XA=$24
tp7=1.13 XA=$76
tp8=1.41 XA=$280
PRICE ACTION ENTRY IDEASellers getting weak as there's no selling momentum recently. Price breakout and still hold at support. Waiting for buyer participation at green zone area for the last confirmation to entry.
TXNP - Cup & Handle Pattern FormationTNXP Daily Chart Analysis:
(1) Cup-Handle pattern formation on the daily chart
(2) On February 09, 2021 company announced the closing of its previously announced
registered direct offering, priced at-the-market, with gross proceeds of approximately $70.0 million.
(3) On March 04, 2021 company announced that it has regained compliance with the minimum bid price
requirement for continued listing on The Nasdaq Global Market.
(4) On March 15, 2021 company announced that 50 percent of the planned total number of participants
have been randomized in the Phase 3 RALLY study (TNX-CY-F306) for the management of fibromyalgia.
(5) On March 17, 2021 company announced preliminary results following vaccination of non-human primates
with TNX-1800 (modified horsepox virus, live vaccine), a live attenuated COVID-19 vaccine candidate
engineered to express the SARS-CoV-2 (CoV-2) spike protein.
A bullish flag formed on the 5min chart on 03/17 so we can expect continued upward momentum into the week's close.
Price Target of $6.00 by end of Q2.
Disclaimer: This written/visual material is comprised of personal opinions and ideas.
It's not late to buyThe 55-day moving average broke down, just the 99-day moving average has remained to lift off.
with the positive result of the COVID-19 vaccine trial, everything is possible.
TONIX Pharma - Not a one trick pony....From what I hear this company has a ton of potential with lots of products and is not just a typical penny stock. Do your own research this is not financial advice.
Nice descending triangle break but lets watch and see if its time to go up.
